Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biomarker Research in Parkinson’s Disease Using Metabolite Profiling

11 Aug 2017

Abstract excerpt

Biomarker research in Parkinson's disease (PD) has long been dominated by measuring dopamine metabolites or alpha-synuclein in cerebrospinal fluid. However, these markers do not allow early detection, precise prognosis or monitoring of disease progression. Moreover, PD is now considered a multifactorial disease, which requires a more precise diagnosis and personalized medication to obtain optimal outcome. In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diet and metabolism studies
Share to Metabolomics and Mass Spectrometry Studies
Share to Microbial Metabolic Engineering and Bioproduction

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28800113
DOI: 10.3390/metabo7030042

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biomarker Research in Parkinson’s Disease Using Metabolite ProfilingPMID 28800113Read ↗

Parkinson’s Disease: Biomarkers, Treatment, and Risk FactorsSemantic proximity Read ↗

The role of dopaminergic medication, lipid, and endocannabinoid pathway alterations in idiopathic and<i>PRKN/PINK1</i>-mediated Parkinson’s disease – a large-scale targeted metabolomics studySemantic proximity Read ↗

LC-MS-based urinary metabolite signatures in idiopathic Parkinson's disease.Semantic proximity Read ↗

Levodopa and dopamine dynamics in Parkinson’s disease metabolomicsSemantic proximity Read ↗

Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson's disease.Semantic proximity Read ↗

Metabolomics of blood reveals age-dependent pathways in Parkinson’s DiseaseSemantic proximity Read ↗

Clinical Sphingolipids Pathway in Parkinson’s Disease: From GCase to Integrated-Biomarker DiscoverySemantic proximity Read ↗

A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot studySemantic proximity Read ↗

Untargeted Plasma Metabolomics Unveils Distinct Metabolite Profiles in Parkinson’s Disease Subtypes: A Focus on idiopathic REM Sleep Behavior DisordersSemantic proximity Read ↗

Metabolic profiling of CSF from people suffering from Sporadic and LRRK2 Parkinson’s disease: a pilot study.Semantic proximity Read ↗

Differences in Blood and Cerebrospinal Fluid Between Parkinson’s Disease and Related DiseasesSemantic proximity Read ↗

Diagnostic biomarkers for Parkinson's disease at a glance: where are we?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.